Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study

Serena Ruggieri(Anna Needs Neuroblastoma Answers), Claudio Gasperini(Nini Hospital), Massimo Filippi(Vita-Salute San Raffaele University), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Carla Tortorella(Carlo Forlanini Hospital), Shalom Haggiag(Carlo Forlanini Hospital), Sergiu Groppa(Johannes Gutenberg University Mainz), Alvino Bisecco(University of Campania "Luigi Vanvitelli"), Nicola De Stefano(University of Siena), Massimiliano Mirabella(Università Cattolica del Sacro Cuore), Christian Enzinger(Medical University of Graz), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Sarmad Al‐Araji(Queen Mary University of London), Matteo Lucchini(Università Cattolica del Sacro Cuore), Maria Laura Stromillo(University of Siena), Afagh Garjani(Nottingham University Hospitals NHS Trust), Àlex Rovira(Centre National de la Recherche Scientifique), Michael Khalil(Medical University of Graz), Olga Ciccarelli(Queen Mary University of London), Luca Prosperini(Nini Hospital), Jordi Río(Universitat Autònoma de Barcelona), Carlo Pozzilli(Sapienza University of Rome), Maria A. Rocca(Vita-Salute San Raffaele University), Antonio Gallo(University of Campania "Luigi Vanvitelli"), Paolo Preziosa(Vita-Salute San Raffaele University), Pietro Annovazzi(Vita-Salute San Raffaele University), Vinzenz Fleischer(Johannes Gutenberg University Mainz), Nikos Evangelou(University of Nottingham)

Journal of Neurology Neurosurgery & Psychiatry

September 29, 2023

Cited by 18

Related Papers

|Annals of Neurology|2011|9.8k

|The Lancet Neurology|2017|8k

|NeuroImage|2006|6.6k

|Annals of Neurology|2005|5k

|Neurology|2014|3.1k